Medicine

Hibernation scientific research harnessed to deal with weight problems as well as tweak metabolic process

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizing the...

CAR- T and also cellular gene therapies are too costly

.Mother Nature Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-...

The WHO genomics program of help equitable implementation of human genomics for international health

.The magazine of the first draft of the human genome pattern in 20011 was actually adhered to due to...

A time-stratified, case\u00e2 $ \"crossover research of heat energy direct exposure and also perinatal mortality from 16 medical facilities in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, our experts mo...

Advancing global antibiotic investigation, advancement as well as gain access to #.\n\nMurray, C. J. L. et al. International problem of microbial antimicrobial resistance in 2019: a step-by-step review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards details dedications and activity in the reaction to antimicrobial protection. Worldwide Frontrunners Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Wellness Company. That publishes checklist of bacteria for which new prescription antibiotics are urgently needed. Planet Health Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Association. WHO microbial priority virus checklist, 2024: bacterial pathogens of hygienics relevance to help investigation, progression as well as strategies to prevent as well as manage antimicrobial resistance. Globe Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entry. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nGlobe Health And Wellness Association. 2023 antibacterial brokers in scientific and preclinical development: a summary and also study. Planet Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Customer review. May 19, 2016 \u00e2 $\" Tackling drug-resistant infections around the globe: final file and suggestions. Evaluation on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB outcomes: documents as well as briefing. Drive AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall structure: an ask for concurrent action on anti-biotics experimentation. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Short 51: How can the EU assistance lasting advancement and accessibility to effective prescription antibiotics? policy choices for existing and also new medications. European Observatory on Health Systems and also Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic make use of and resistance\u00e2 $\" showing the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Wellness Association. 2021 Mindful classification. That get access to, check out, get, distinction of anti-biotics for analysis as well as tracking of use. Globe Wellness Company https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Facility for Disease Deterrence as well as Command. Antimicrobial protection aim ats: exactly how can our experts reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Health And Wellness Organization. Absence of development set to undermine antibiotic performance and wellness gains. World Wellness Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. How antimicrobial resistance is linked to temperature adjustment: a review of two entwined global challenges. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: we need to have critical activity and financial investment that pay attention to the weakest hyperlink. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Institution. Immunization insurance coverage. Globe Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection protection and also management in low-resource setups: the need for the local area, the contextual and the practical. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of applying antimicrobial stewardship devices in low to mid profit nations (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief history of the antibiotic age: lessons discovered and difficulties for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Client access in 14 high-income nations to new antibacterials approved by the US Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals and also Medical Tools Agency, or even Health Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Company. 2021 antibacterial brokers in clinical as well as preclinical progression: an outline as well as evaluation. Globe Wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics should sustain the science. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of innovation in antibacterial therapies. Biotechnology Innovation Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Assessing specialist application of next-generation anti-biotics versus resistant Gram-negative infections in U.S. hospitals: a retrospective associate research. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in anti-bacterial rehabs. Biotechnology Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic assessment and important evaluation of reward techniques for exploration as well as progression of unique prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth And Wellness Unexpected Emergency Preparedness and Response Authority. R &amp d of health care countermeasures. International Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Commission. Pre-draft plan for an European relationship under Horizon Europe One Wellness Antimicrobial Protection. International Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic Trial And Error Collaboration. Entasis Therapies as well as the Worldwide Prescription Antibiotic Research Study &amp Advancement Relationship to establish a new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of business- and non-industry-sponsored professional trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Wellness Organization. Number of professional test registrations by site, illness, period of advancement, grow older as well as sexual activity of trial individuals (1999\u00e2 $ \"2022). Globe Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Prescription Antibiotic R &amp D Collaboration. NeoSept1: a study to figure out the position of existing and also new antibiotics combos to deal with newborns that remain in healthcare facility along with serious blood poisoning. ISRCTN computer registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Organization of Canada. Government of Canada brings in important expenditure to eliminate antimicrobial resistance (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic Research and Development Partnership. Asia government backing supports GARDP\u00e2 $ s efforts to resist antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Structure. Novo Nordisk Groundwork partners along with CARB-X to combat drug-resistant contaminations. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health and Digital Manager Firm. Study on delivering AMR clinical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the necessary dimension of global pull incentives for antibacterial medicines. Wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimension a market entry benefit for the development of new antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Business rewards as well as antibiotic protection: an intro to the antibiotic susceptibility reward. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG advanced dedication for subscription-based buying of unfamiliar antimicrobials as well as its assumed roi. Facility for Global Growth https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 assets in brand new prescription antibiotics will settle \u00e2 $\" for everyone. Workplace of Health and wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves war against deadly diseases observing productive world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Payment. Reform of the EU pharmaceutical legalisation. European Percentage https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Compensation styles to confront market failings for antimicrobials: methods taken in France, Germany, Sweden, the United Kingdom, and the United States. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers and also Organizations. From protection to strength: what could the future antibiotic pipe resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Center &amp Globe Health Organization. Incentivising the development of brand new antibacterial procedures: 2023 progress report by the Global AMR R&ampD Center and WHO. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration style for prescription antibiotics looked at effective? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" novel stimulations for the development as well as going on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and nationwide sources of youngster death in 2000\u00e2 $ \"13, along with estimates to update post-2015 priorities: an improved systematic review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Antibacterial medication lacks coming from 2001 to 2013: ramifications for professional training. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medicine shortages: description and also styles from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Evaluation of WHO antibiotic usage and also access aim ats in 76 nations, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the fakes: dealing with low-grade and falsified medicines. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it obtaining much easier to secure antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Culture for Lab Medication. Policy concise and also infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic consumption for human make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research. Trop. Med. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: analysis of core stockrooms products to in-patient treatment wellness establishments coming from 2017 to 2019 in Uganda. Trop. Med. Contaminate. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et al. Variations in the consumption of antimicrobial medications in the European region, 2014\u00e2 $ \"2018: findings as well as effects from ESAC-Net and WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Medication shortage: sources, influence, and also mitigation approaches. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Person accessibility in 14 high-income nations to new antibacterials authorized due to the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Tools Firm, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost antibiotics: a follow-up inventory research in Europe, the U.S.A., Canada and also Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health innovation for international health. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Partnership. The 2023 AMR Sector Collaboration development poll: production and also the setting. amr Business Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can health care products be actually developed on a non-profit basis? Exploring product advancement partnerships for neglected diseases. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the international public interest. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Disease Management and also Prevention. Africa CDC pioneers vibrant move to secure Africa\u00e2 $ s health and wellness future by creating a 50 billion dollar health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Discussing public-health patent licensing contracts to raise accessibility to wellness innovations: an insider\u00e2 $ s story. BMJ Glob. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service models for experimentation along with affordability demands are needed to attain reasonable prices of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Microorganisms Biopharmaceutical Gas. Conservation as well as get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Prescription Antibiotic Experimentation Alliance. Shinogi, GARDP and CHAI introduce site license and also partnership agreements to treat microbial diseases by growing accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Partnership. Leaving the laboratory: tracking the downtrend in AMR R&ampD specialists. amr Business Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 phone call to action on antimicrobial protection. G7G20 Papers Data bank https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Union on Aging &amp Infectious Health Conditions Culture of America. 2024 AMR readiness index progress report. Measuring federal government activity on AMR policy. Global Coalition on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and also Agriculture Association of the United Nations, United Nations Environment Programme, Planet Health Association &amp. Globe Company for Creature Wellness. International data source for tracking antimicrobial resistance (AMR): country self-assessment survey (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Overview: AMR belongs in the wi...

Integrating liver endpoints in clinical tests of cardiovascular and also kidney disease

.Attributes Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpo...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial cleverness assisted screening process for cardiomyopathies in an obstetric populace: a practical randomized professional test

.Trial layout as well as oversightThe Assessment for PEripartum Cardiomyopathies along with Artifici...

Sustained HIV remission after allogeneic hematopoietic stalk cell hair transplant along with wild-type CCR5 donor tissues

.Attributes Medicine, Released online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remissio...

Senolytics target cellular senescence-- but can they decrease growing old?

.In the 1960s, US anatomist Leonard Hayflick noticed that replicative cells possess a minimal number...